Previous close | 110.59 |
Open | 111.10 |
Bid | 106.40 x 100 |
Ask | 106.90 x 100 |
Day's range | 105.95 - 112.00 |
52-week range | 62.55 - 163.24 |
Volume | |
Avg. volume | 4,413,549 |
Market cap | 40.8B |
Beta (5Y monthly) | 1.60 |
PE ratio (TTM) | N/A |
EPS (TTM) | -12.33 |
Earnings date | 02 May 2024 - 06 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 121.94 |
Moderna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage studies. It also secures $750 million in funding from Blackstone to advance its influenza program.
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.